Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,086 | -48,053 | -35,379 | -226,539 | -164,808 |
| Depreciation Amortization | -7,776 | -6,048 | -2,875 | -8,608 | -5,582 |
| Accounts receivable | -15,402 | -12,085 | -3,839 | -6,095 | -3,125 |
| Other Working Capital | -21,643 | -33,749 | -48,522 | -3,064 | -50,501 |
| Other Operating Activity | 60,100 | 44,883 | 36,931 | 149,165 | 137,793 |
| Operating Cash Flow | $-46,807 | $-55,052 | $-53,684 | $-95,141 | $-86,223 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 35,245 | 26,697 | 28,991 | -129,330 | -101,411 |
| PPE Investments | -449 | -390 | -235 | -2,168 | -1,614 |
| Investing Cash Flow | $34,796 | $26,307 | $28,756 | $-131,498 | $-103,025 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 300,000 | 300,000 |
| Debt Repayment | N/A | N/A | -390 | -261,713 | -261,713 |
| Common Stock Issued | 4,059 | 1,968 | 1,692 | 8,682 | 8,518 |
| Other Financing Activity | -5,799 | -4,982 | -2,350 | -14,484 | -11,147 |
| Financing Cash Flow | $-1,740 | $-3,014 | $-1,048 | $32,485 | $35,658 |
| Exchange Rate Effect | 368 | -483 | -340 | 362 | -160 |
| Beginning Cash Position | N/A | N/A | 112,447 | 306,239 | 306,239 |
| End Cash Position | -13,383 | -32,242 | 86,131 | 112,447 | 152,489 |
| Net Cash Flow | $-13,383 | $-32,242 | $-26,316 | $-193,792 | $-153,750 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,807 | -55,052 | -53,684 | -95,141 | -86,223 |
| Capital Expenditure | -449 | -390 | -235 | -2,168 | -1,614 |
| Free Cash Flow | -47,256 | -55,442 | -53,919 | -97,309 | -87,837 |